Profound Medical (PROF) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.01, -4.75% vs the prior close of $6.31.
- Volume 130.92K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PROF slides 4.8% to $6.01, 4 down days in a row. Closed at $6.01, -4.75% vs the prior close of $6.31. Day range $6.01β$6.34, opened at $6.33.
PROF daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β PROF slides 4.8% to $6.01, 4 down days in a row
- Closed at $6.01, -4.75% vs the prior close of $6.31. Day range $6.01β$6.34, opened at $6.33.
- Volume was 130.92K shares, 0.6x its 50-day average of 202.06K.
- Price is -6.8% vs its 50-day average ($6.45) and -11.4% vs its 200-day average ($6.79).
- 52-week range $4.80β$8.95; today's close sits at 29% of that range, 32.8% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 β PROF slides 4.7% to $6.31, 3 down days in a row
- Closed at $6.31, -4.68% vs the prior close of $6.62. Day range $6.27β$6.74, opened at $6.58.
- Volume was 175.00K shares, 0.9x its 50-day average of 200.54K.
- Price is -2.7% vs its 50-day average ($6.48) and -7.1% vs its 200-day average ($6.79).
- 52-week range $4.80β$8.95; today's close sits at 36% of that range, 29.5% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 β PROF slides 5.6% to $6.62
- Closed at $6.62, -5.56% vs the prior close of $7.01. Day range $6.53β$7.12, opened at $7.01.
- Volume was 260.90K shares, 1.3x its 50-day average of 197.38K.
- Price is +1.6% vs its 50-day average ($6.52) and -2.6% vs its 200-day average ($6.80).
- 52-week range $4.80β$8.95; today's close sits at 44% of that range, 26.0% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 β PROF slides 3.3% to $7.01 on 1.9x normal volume
- Closed at $7.01, -3.31% vs the prior close of $7.25. Day range $6.84β$7.19, opened at $7.19.
- Volume was 374.20K shares, 1.9x its 50-day average of 194.40K β unusually heavy trading.
- Price is +7.0% vs its 50-day average ($6.55) and +3.1% vs its 200-day average ($6.80).
- 52-week range $4.80β$8.95; today's close sits at 53% of that range, 21.7% below the 52-week high.
Oct 12, 2026 β PROF jumps 5.1% to $7.25, a 1-month high
- Closed at $7.25, +5.07% vs the prior close of $6.90. Day range $6.80β$7.40, opened at $6.93.
- Volume was 300.00K shares, 1.6x its 50-day average of 189.05K.
- Price is +10.2% vs its 50-day average ($6.58) and +6.5% vs its 200-day average ($6.80).
- 52-week range $4.80β$8.95; today's close sits at 59% of that range, 19.0% below the 52-week high.
Oct 9, 2026 β PROF ends flat (-0.1%) to $6.90 on 2.3x normal volume
- Closed at $6.90, -0.14% vs the prior close of $6.91. Day range $6.80β$7.25, opened at $6.97.
- Volume was 420.10K shares, 2.3x its 50-day average of 181.27K β unusually heavy trading.
- Price is +4.9% vs its 50-day average ($6.58) and +1.4% vs its 200-day average ($6.81).
- 52-week range $4.80β$8.95; today's close sits at 51% of that range, 22.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 β PROF jumps 21.7% to $6.91, a 1-month high on 23.5x normal volume
- Closed at $6.91, +21.65% vs the prior close of $5.68. Day range $6.04β$6.92, opened at $6.50.
- Volume was 2.97M shares, 23.5x its 50-day average of 126.71K β unusually heavy trading.
- Price is +4.9% vs its 50-day average ($6.59) and +1.5% vs its 200-day average ($6.81).
- 52-week range $4.80β$8.95; today's close sits at 51% of that range, 22.8% below the 52-week high.
Oct 7, 2026 β PROF slides 6.6% to $5.68 on 3.3x normal volume
- Closed at $5.68, -6.58% vs the prior close of $6.08. Day range $5.65β$6.11, opened at $6.00.
- Volume was 395.20K shares, 3.3x its 50-day average of 120.43K β unusually heavy trading.
- Price is -13.9% vs its 50-day average ($6.59) and -16.6% vs its 200-day average ($6.81).
- 52-week range $4.80β$8.95; today's close sits at 21% of that range, 36.5% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 6, 2026 β PROF rises 0.8% to $6.08
- Closed at $6.08, +0.83% vs the prior close of $6.03. Day range $6.01β$6.34, opened at $6.10.
- Volume was 168.00K shares, 1.3x its 50-day average of 128.96K.
- Price is -8.2% vs its 50-day average ($6.63) and -10.9% vs its 200-day average ($6.82).
- 52-week range $4.80β$8.95; today's close sits at 31% of that range, 32.1% below the 52-week high.
Oct 5, 2026 β PROF jumps 3.3% to $6.03
- Closed at $6.03, +3.25% vs the prior close of $5.84. Day range $5.84β$6.15, opened at $5.84.
- Volume was 133.60K shares, 1.0x its 50-day average of 131.74K.
- Price is -9.3% vs its 50-day average ($6.65) and -11.7% vs its 200-day average ($6.83).
- 52-week range $4.80β$8.95; today's close sits at 30% of that range, 32.6% below the 52-week high.
Oct 2, 2026 β PROF ends flat (-0.2%) to $5.84
- Closed at $5.84, -0.17% vs the prior close of $5.85. Day range $5.79β$6.00, opened at $5.89.
- Volume was 67.80K shares, 0.5x its 50-day average of 130.65K β lighter than usual.
- Price is -12.5% vs its 50-day average ($6.67) and -14.6% vs its 200-day average ($6.84).
- 52-week range $4.80β$8.95; today's close sits at 25% of that range, 34.7% below the 52-week high.
PROF latest news & SEC filings
Every SEC filing by or about PROF in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Oct 9, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Oct 7, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 4, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Sep 3, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 17, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 17, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 6, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.48M (prior year $2.21M) (+12.3% vs Jun 30, 2025)
- Net income: -$9.54M (prior year -$15.70M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.26 (prior year -$0.52) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Jul 16, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Jul 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade PROF
- Last results release: Oct 7, 2026 (8-K Item 2.02). Previous ones: Aug 6, 2026, May 7, 2026, Mar 5, 2026. Based on that rhythm, the next report is likely around Jan 6, 2027 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.99% (largest 21.7%). That is a volatile stock.
- Liquidity: about 332.36K shares (β$2.00M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $6.01 vs a range of $4.80β$8.95 (29% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 9, 2026; 8-K Oct 7, 2026.
- Share count: 36.53M shares outstanding (Aug 6, 2026), +21.6% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
PROF market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.33 | 6.34 | 6.01 | 6.01 | 130.92K |
| Oct 15, 2026 | 6.58 | 6.74 | 6.27 | 6.31 | 175.00K |
| Oct 14, 2026 | 7.01 | 7.12 | 6.53 | 6.62 | 260.90K |
| Oct 13, 2026 | 7.19 | 7.19 | 6.84 | 7.01 | 374.20K |
| Oct 12, 2026 | 6.93 | 7.40 | 6.80 | 7.25 | 300.00K |
| Oct 9, 2026 | 6.97 | 7.25 | 6.80 | 6.90 | 420.10K |
| Oct 8, 2026 | 6.50 | 6.92 | 6.04 | 6.91 | 2.97M |
| Oct 7, 2026 | 6.00 | 6.11 | 5.65 | 5.68 | 395.20K |
| Oct 6, 2026 | 6.10 | 6.34 | 6.01 | 6.08 | 168.00K |
| Oct 5, 2026 | 5.84 | 6.15 | 5.84 | 6.03 | 133.60K |
| Oct 2, 2026 | 5.89 | 6.00 | 5.79 | 5.84 | 67.80K |
| Oct 1, 2026 | 5.83 | 5.98 | 5.66 | 5.85 | 156.40K |
| Sep 30, 2026 | 5.71 | 5.91 | 5.65 | 5.80 | 106.90K |
| Sep 29, 2026 | 5.97 | 5.97 | 5.71 | 5.72 | 77.70K |
| Sep 28, 2026 | 5.67 | 5.95 | 5.61 | 5.92 | 58.40K |
| Sep 25, 2026 | 5.70 | 5.86 | 5.61 | 5.76 | 265.30K |
| Sep 24, 2026 | 5.69 | 5.83 | 5.60 | 5.60 | 178.80K |
| Sep 23, 2026 | 5.84 | 6.00 | 5.64 | 5.74 | 82.20K |
| Sep 22, 2026 | 6.19 | 6.19 | 5.86 | 5.89 | 87.90K |
| Sep 21, 2026 | 5.96 | 6.40 | 5.96 | 6.10 | 233.60K |
About Profound Medical
Profound Medical (PROF) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in MISSISSAUGA, Ontario, Canada. State of incorporation: Ontario, Canada. Fiscal year ends December 31. SEC CIK 1628808.
PROF board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PROF financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $-42.57M | 1.41 | $-38.21M |
| Dec 31, 2024 | $9.74M | $-27.82M | 1.12 | $-23.45M |
| Dec 31, 2023 | $5.90M | $-28.32M | 1.34 | $-22.61M |
Latest balance sheet: total assets $62.38M, total liabilities $12.58M, cash $38.27M (as of Jun 30, 2026).
PROF earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 7, 2026 | 8-K Item 2.02 (results) | $5.68 |
| Aug 6, 2026 | 8-K Item 2.02 (results) | $7.94 |
| May 7, 2026 | 8-K Item 2.02 (results) | $7.16 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $7.49 |
| Oct 7, 2025 | 8-K Item 2.02 (results) | $6.46 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $5.54 |
| May 8, 2025 | 8-K Item 2.02 (results) | $4.98 |
| Mar 7, 2025 | 8-K Item 2.02 (results) | $6.86 |
| Jan 8, 2025 | 8-K Item 2.02 (results) | $7.68 |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PROF
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.